JSMO Announces Guidance on Prevention and Treatment of Tumor Lysis Syndrome; Rasburicase Recommended for High-risk Patients

The Japanese Society of Medical Oncology (JSMO) has drawn up a “Tumor Lysis Syndrome (TLS) Guidance” that specifies methods for preventing and treating TLS based on a three-grade risk classification. Adding to the views of an overseas panel of experts...read more